Autoantibodies against aminoacyl-tRNA synthetase: Novel diagnostic marker for type 1 diabetes mellitus

Biomarkers

Volumn 15, Issue 4, 2010, Pages 358-366

  Park, Sang Gyu ^a   Park, Ho Seon ^b   Jeong, In Kyong ^b   Cho, Young Min ^b   Lee, Hong Kyu ^b   Kang, Young Sun ^c   Kim, Sunghoon ^b   Park, Kyong Soo ^b  

^a CHA University   (South Korea)

^b Seoul National University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Antisynthetase syndrome; Autoantibody; Autoimmune disease; ELISA; Pancreas

Indexed keywords

ALANINE TRANSFER RNA LIGASE; AMINO ACID TRANSFER RNA LIGASE; ASPARTATE TRANSFER RNA LIGASE; AUTOANTIBODY; TRYPTOPHAN TRANSFER RNA LIGASE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; SENSITIVITY AND SPECIFICITY;

ADULT; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; PANCREAS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 77952517565     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547501003777823     Document Type: Article

References (42)

1. Adam AC, Grohe C, Stier S, Gattenlohner S, Balta Z, Buttner R, Gutgemann I. (2007). Hodgkin's lymphoma in a patient with Jo-1 syndrome. Virchows Arch 451:101-4.
2. Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Johnson EB, Motheral T, Putnam A, Crowe PD, Ling N, Boehme SA, Conlon PJ. (2002). Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51:2126-34.
3. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee SQ, Jordanova A, Kremensky I, Christodoulou K, Middleton LT, Sivakumar K, Ionasescu V, Funalot B, Vance JM, Goldfarb LG, Fischbeck KH, Green ED. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72:1293-9.
4. Bilbao JR, Rica I, Vazquez JA, Busturia MA, Castano L. (2000). Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients. Horm Res 54:181-5.
5. Boasso A, herbeuval JP, Hardy AW, Winkler C, Shearer GM. (2005). Regulation of indoleamine 2, 3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-Fc in human CD4+ T cells. Blood 105:1574-81.
6. Bougneres PF, Landais P, Boisson C, Carel JC, Frament N, Boitard C, Chaussain JL, Bach J F. (1990). Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 39:1264-72.
7. Casares S, Hurtado A, Mcevoy RC, Sarukhan A, Von Boehmer H, Brumeanu TD. (2002). Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol 3:383-91.
8. Dyck PJ, Lambert EH. (1968). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18:619-25.
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. (2003). Diabetes Care 26 (Suppl. 1):[S5-20.
10. Favorova OO, Zargarova TA, Rukosuyev VS, Beresten SF, Kisselev LL. (1989). Molecular and cellular studies of tryptophanyl-tRNA synthetases using monoclonal antibodies. Remarkable variations in the content of tryptophanyl-tRNA synthetase in the pancreas of different mammals. Eur J Biochem 184:583-8.
11. Hirakata M, Suwa A, Takeda Y, Matsuoka Y, Irimajiri S, Targoff IN, Hardin JA, Craft J. (1996). Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity. Arthritis Rheumatism 39:146-51.
12. Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciol-Rosen L, Hartlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ. (2002). Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 196:781-91.
13. Jordanova A, Irobi J, Tomas FP, Van Dijck P, Meerschaert K, Dewil M, Dierick I, Jacobs A, De Vriendt E, Guergueltcheva V, Rao C V, Tournev I, Gondim FA, D'hooghe M, Van Gerwen V, Callaerts P, Van Den Bosch L, Timmermans JP, Robberecht W, Gettemans J, Thevelein JM, De Jonghe P, Kremensky I, Timmerman V. (2006). Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38:197-202.
14. Kaminska M, Shalak V, Francin M, Mirande M. (2007). Viral hijacking of mitochondrial lysyl-tRNA synthetase. J Virol 81:68-73.
15. Kantarova D, Buc M. (2007). Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res 56:255-66.
16. Kawasaki E, Matsuura N, Eguchi K. (2006). Type 1 diabetes in Japan. Diabetologia 49:828-36.
17. Kisselev LL, Justesen J, Wolfson AD, Frolova LY. (1998). Diadenosine oligophosphates (Ap (n) A), a novel class of signalling molecules? FEBS Lett 427:157-63.
18. Knip M, Siljander H. (2008). Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7:550-7.
19. Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, Kuwana M, Fukuda Y. (2010). Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Int Med 49:361-9.
20. Ko YG, Kim EY, Kim T, Park H, Park HS, Choi EJ, Kim S. (2001). Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 276:6030-6.
21. Kovaleski BJ, Kennedy R, Hong MK, Datta SA, Kleiman L, Rein A, Musier-Forsyth K. (2006). In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase. J Biol Chem 281:19449-56.
22. Kron MA, Petridis M, Haertlein M, Libranda-Ramirez B, Scaffidi LE. (2005). Do tissue levels of autoantigenic aminoacyl-tRNA synthetase predict clinical disease? Med Hypoth 65:1124-7.
23. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL. (2006). Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443:50-5.
24. Mathews MB, Bernstein RM. (1983). Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304:177-9.
25. Mauricio D, De Leiva A. (2001). Autoimmune gestational diabetes mellitus:a distinct clinical entity? Diabet Metab Res Rev 17:422-8.
26. Nangle LA, Motta CM, Schimmel P. (2006). Global effects of mistranslation from an editing defect in mammalian cells. Chem Biol 13:1091-100.
27. Nangle LA, Zhang W, Xie W, Yang XL, Schimmel P. (2007). Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Nat Acad Sci USA 104:11239-44.
28. Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, Mathis D. (2006). Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311:1775-8.
29. Park SG, Ewalt KL, Kim S. (2005a). Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 30:569-74.
30. Park SG, Kang YS, Kim JY, Lee CS, Ko YG, Lee WJ, Lee KU, Yeom YI, Kim S. (2006). Hormonal activity of AIMP1/p43 for glucose homeostasis. Proc Nat Acad Sci USA 103:14913-18.
31. Park SG, Kim HJ, Min YH, Choi EC, Shin YK, Park BJ, Lee SW, Kim S. (2005b). Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Nat Acad Sci USA 102:6356-61.
32. Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, Mccarthy B, Mccanlies E, Dorman J, Trucco M. (1996). The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241-5. (Pubitemid 26070350)
33. Riley WJ. (1992). Autoimmune polyglandular syndromes. Horm Res 38:9-15.
34. Sakumai M, Yachie A, Kasahara Y. (2007). [Role of T cells in the pathogenesis of type I diabetes mellitus: structure analysis of complementarity determining region 3 of circulating T cells]. Rinsho Byori 55:112-19.
35. Scheinker VS, Beresten S F, Mazo AM, Ambartsumyan NS, Rokhlin O V, Favorova OO, Kisselev LL. (1979). Immunochemical studies of beef pancreas tryptophanyl-tRNA synthetase and its fragments. Determination of the number of antigenic determinants and a comparison with tryptophanyl-tRNA synthetases from other sources and with reverse transcriptase from avian myeloblastosis virus. Eur J Biochem 97:529-40.
36. Scheper GC, Van Der Klok T, Van Andel RJ, Van Berkel CG, Sissler M, Smet J, Muravina TI, Serkov SV, Uziel G, Bugiani M, Schiffmann R, Krageloh-Mann I, Smeitink JA, Florentz C, Van Coster R, Pronk JC, Van Der Knaap MS. (2007). Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534-9.
37. Taplin CE, Barker JM. (2008). Autoantibodies in type 1 diabetes. Autoimmunity 41:11-18.
38. Tisch R, Liblau RS, Yang XD, Liblau P, Mcdevitt HO. (1998). Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894-9.
39. Tzima E, Reader JS, Irani-Tehrani M, Ewalt KL, Schwartz MA, Schimmel P. (2005). VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function. J Biol Chem 280:2405-8.
40. Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P. (2002). A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Nat Acad Sci USA 99:173-7. (Pubitemid 34060336)
41. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC. (2007). The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Nat Acad Sci USA 104:17040-5.
42. Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T. (2006). Antiaminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39:233-41.